Omada Health expands its platform to include cholesterol management, enhancing integrated care for chronic conditions.
Quiver AI Summary
Omada Health has announced the expansion of its healthcare platform to include dedicated cholesterol management, complementing its existing support for weight, glucose, blood pressure, and GLP-1. This addition addresses the significant challenge of high cholesterol, particularly among adults with obesity and cardiovascular disease, where traditional care often falls short due to episodic management. Omada's approach integrates behavior change techniques and medication adherence into everyday routines, aiming to reduce cardiovascular risks and enhance long-term health outcomes. The program employs a combination of human coaches and AI technology, ensuring a comprehensive, connected care model that emphasizes continuous support rather than isolated treatments. With the launch of this initiative in collaboration with a leading employer, Omada aims to meet the growing demand for integrated cholesterol care, promoting sustained engagement and healthier lifestyles among its members.
Potential Positives
- Omada Health expands its integrated platform to include dedicated cholesterol management, addressing a significant health concern for a large segment of the population.
- The new service aims to provide continuous support for cholesterol management, promoting day-to-day behavior change rather than episodic care, thereby improving long-term cardiovascular risk outcomes.
- The launch of "Omada for Cholesterol" demonstrates the company's responsiveness to market demand for comprehensive chronic care solutions, enhancing its position in the healthcare landscape.
- Omada Health has served over one million members since its inception, indicating strong market presence and potential for growth within the chronic care sector.
Potential Negatives
- The press release highlights a significant gap in cholesterol management in the healthcare system, potentially implying that prior offerings from the company may have inadequately addressed cardiovascular risks.
- The announcement of a new service indicates that the company felt the need to adapt its platform in response to existing deficiencies in managing cardiovascular health, which may raise questions about the effectiveness of its previous services.
- The focus on cholesterol management suggests that Omada Health may have previously overlooked this critical area in their care model, potentially affecting their reputation in chronic care management.
FAQ
What new features has Omada Health introduced?
Omada Health has expanded its platform to include dedicated cholesterol management alongside support for weight, glucose, and blood pressure.
How does Omada for Cholesterol work?
Omada for Cholesterol utilizes a compassionate intelligence model combining human coaching and AI to provide ongoing support for cholesterol management.
Why is cholesterol management important?
High cholesterol is a significant driver of cardiovascular risk, and addressing it consistently can lower the chance of serious health events like heart attacks.
Who can benefit from Omada's services?
Omada's services are designed for adults with chronic conditions such as obesity and cardiovascular diseases, providing necessary support beyond traditional care.
How does Omada Health integrate with existing healthcare?
Omada Health complements primary and specialty care by focusing on continuous behavior change and risk reduction, rather than only measuring cholesterol during visits.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OMDA Insider Trading Activity
$OMDA insiders have traded $OMDA stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $OMDA stock by insiders over the last 6 months:
- SEAN P. DUFFY (Chief Executive Officer) has made 0 purchases and 4 sales selling 280,541 shares for an estimated $4,388,304.
- WEI-LI SHAO (President) sold 5,618 shares for an estimated $90,645
- STEVEN L. COOK (Chief Financial Officer) sold 4,211 shares for an estimated $64,704
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OMDA Revenue
$OMDA had revenues of $68M in Q2 2025. This is an increase of 65.07% from the same period in the prior year.
You can track OMDA financials on Quiver Quantitative's OMDA stock page.
$OMDA Hedge Fund Activity
We have seen 96 institutional investors add shares of $OMDA stock to their portfolio, and 56 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- REVELATION CAPITAL MANAGEMENT, LLC added 5,208,034 shares (+inf%) to their portfolio in Q4 2025, for an estimated $82,182,776
- MILLENNIUM MANAGEMENT LLC added 2,096,705 shares (+1195.0%) to their portfolio in Q4 2025, for an estimated $33,086,004
- CITADEL ADVISORS LLC added 1,245,277 shares (+5330.1%) to their portfolio in Q4 2025, for an estimated $19,650,471
- A16Z CAPITAL MANAGEMENT, L.L.C. removed 1,153,645 shares (-25.0%) from their portfolio in Q4 2025, for an estimated $18,204,518
- JEFFERIES FINANCIAL GROUP INC. added 1,073,991 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,947,577
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 910,344 shares (-66.0%) from their portfolio in Q4 2025, for an estimated $14,365,228
- MADRYN ASSET MANAGEMENT, LP added 583,800 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,212,364
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OMDA Analyst Ratings
Wall Street analysts have issued reports on $OMDA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/05/2026
- BMO Capital issued a "Outperform" rating on 11/13/2025
- Needham issued a "Buy" rating on 11/07/2025
- Evercore ISI Group issued a "Outperform" rating on 11/07/2025
To track analyst ratings and price targets for $OMDA, check out Quiver Quantitative's $OMDA forecast page.
$OMDA Price Targets
Multiple analysts have issued price targets for $OMDA recently. We have seen 6 analysts offer price targets for $OMDA in the last 6 months, with a median target of $25.5.
Here are some recent targets:
- Ryan MacDonald from Needham set a target price of $28.0 on 01/22/2026
- Stan Berenshteyn from Wells Fargo set a target price of $17.0 on 01/09/2026
- Saket Kalia from Barclays set a target price of $22.0 on 01/05/2026
- Sean Dodge from BMO Capital set a target price of $27.0 on 11/13/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $28.0 on 11/07/2025
- Vikram Kesavabhotla from Baird set a target price of $24.0 on 09/05/2025
Full Release
SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, today announced the expansion of its integrated platform to include dedicated cholesterol management alongside weight, glucose, blood pressure, and GLP-1 support. Up to 70% of adults with obesity have high cholesterol, 1 yet among U.S. adults with atherosclerotic cardiovascular disease, only 41% ever reached a healthy LDL-C level (<70 mg/dL). 2 This gap underscores a core challenge in traditional care models that are not designed to sustain the day-to-day behaviors required to improve cholesterol numbers over time.
“High cholesterol rarely exists in isolation 1,3,4 and is a primary driver of cumulative cardiovascular risk, 5 yet it is often managed episodically or without sustained support, 1 ” said Thomas Tsang, MD, MPH, Chief Medical Officer at Omada Health. “When we help members improve their cholesterol through behavior change and medication adherence, we’re not just improving lipid levels; we’re meaningfully lowering cumulative cardiovascular risk and the likelihood of costly, acute events like heart attacks and strokes. 6,7 Evidence from Omada’s lifestyle change programs has already shown that virtual, behavior-first interventions can improve multiple cardiometabolic risk factors, including cholesterol, underscoring the importance of adding dedicated cholesterol support to our care model. 8 ”
High cholesterol is a core driver of cardiovascular risk 5 , yet standard care still manages it through periodic labs and brief visits 1 rather than day‑to‑day support. Omada for Cholesterol is built on Omada’s compassionate intelligence model of human-led coaching amplified by AI to address cholesterol as part of the same interconnected cardiometabolic system as weight, blood pressure, and diabetes, instead of another siloed benefit. Multidisciplinary care teams, including health coaches and cardiometabolic specialists, connect nutrition, activity, behavior change support, and medication adherence guidance to help members’ reach their cholesterol goals.
“Launching with a market-leading employer is a signal that there is a need for between-visit cholesterol care that properly addresses long-term cardiovascular risk in their populations,” said Sean Duffy, CEO & Co‑Founder of Omada Health. “Because of our flexible infrastructure, we were able to quickly add cholesterol support on our existing platform, giving customers one partner for integrated cardiometabolic care in response to their demand.”
Omada for Cholesterol is designed to complement primary and specialty care by addressing how cardiovascular risk builds over time, not just how it’s measured in visits. By keeping members engaged in day-to-day behavior change across nutrition, activity, and medication adherence, Omada helps bend the curve of cardiovascular disease, rather than reacting only after acute events occur.
About Omada Health
Omada Health (Nasdaq: OMDA) is on a mission to fix what’s broken in chronic care. Today's healthcare system poorly serves chronic conditions that require ongoing support between doctor visits, like obesity, diabetes, hypertension, and musculoskeletal disorders. Omada’s virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy. Omada has served more than one million members since launch across 2,000+ employers, health plans, and health systems. Learn more at
omadahealth.com
.
Contacts
Rose Ramseth
[email protected]
Citations
- Lim Y, Haq N, Boster J. Obesity and comorbid conditions. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK574535/.
- MacDougall DE, Ferdinand K, Baum SJ, et al. Cholesterol management in US adults with ASCVD in the Family Heart Database during 2022–23: Current state of care and opportunities for improvement. Am J Prev Cardiol. 2025;24:101354. doi:10.1016/j.ajpc.2025.101354.
- American Heart Association. Know your risk factors for high blood pressure. Available at: https://www.heart.org/en/health-topics/high-blood-pressure/know-your-risk-factors-for-high-blood-pressure. Accessed February 12, 2026.
- Centers for Disease Control and Prevention. Prevalence of self-reported high cholesterol in adults with diabetes, aged 18 years or older, United States, 2021. Behavioral Risk Factor Surveillance System. Available at: https://nccd.cdc.gov/Toolkit/DiabetesBurden/SelfReported/Hc. Accessed February 12, 2026.
- American Heart Association. Prevention and treatment of high cholesterol (hyperlipidemia). Available at: https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol-hyperlipidemia. Accessed February 12, 2026.
- American Heart Association. Lifestyle changes to prevent a heart attack. Available at: https://www.heart.org/en/health-topics/heart-attack/life-after-a-heart-attack/lifestyle-changes-for-heart-attack-prevention. Accessed February 12, 2026.
- Palaniappan LP, Allen NB, Almarzooq ZI, et al. 2026 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2026;[Epub ahead of print].
- Castro Sweet CM, Chiguluri V, Gumpina R, et al. Outcomes of a Digital Health Program With Human Coaching for Diabetes Risk Reduction in a Medicare Population. J Aging Health. 2018;30(5):692-710. doi:10.1177/0898264316688791